The last decade in biopharmaceutical manufacturing has brought a considerable amount of change to how drugs are developed and manufactured. Advances in science and technology have resulted in more diversified pipelines with increasingly complex molecules. Seeking faster ways to bring novel drugs to market while meeting stringent product quality...
As of the end of April, the World Health Organization was in preclinical trials, with five additional candidates already in clinical trials. Given how recently the COVID-19 pandemic began spreading, it might seem promising that there’s already a lot of activity on the immunization front.
With so many potential...
Epidemiologists or "disease detectives" will say it takes at least 10 years, on average, to develop, test and produce a new anti-viral vaccine.
Given this tedious timescale, news that biotech and pharmaceutical firms worldwide are aiming to have a new vaccine against COVID-19 available in as little as only 18 months is historic and unheard of.
Th...
B iopharmaceutical manufacturing uses living cells to produce therapies that treat diseases like cancer, diabetes, and autoimmune disorders. Manufacturing medicine using biology presents different challenges from the traditional chemical manufacturing processes that stamp out identical pressed pills.
Biomanufacturing processes are hard to control...
In my capacity as the Chair of the Council of the 91¿´Æ¬ institute directors, I often get asked about trends in U.S. advanced manufacturing. When I receive a question like this, I try to think about advanced manufacturing as broadly as possible — and consider technologies that could stand to benefit most manufacturers, as well as the U...
